1-4 of 4
Devendra K. Hiwase, MD
Close
Sort by
Journal Articles

Proton Pump Inhibitors Augment Nilotinib and Dasatinib Mediated Bcr-Abl Kinase Inhibition

Devendra K Hiwase, MD, MBBS, FRACP, FRCPA, Laura Eadie, Verity Saunders, Timothy Hughes, MD, MBBS, Deborah L. White, PhD
Journal: Blood
Blood (2010) 116 (21): 3991.
https://doi.org/10.1182/blood.V116.21.3991.3991
Published: 2010
Journal Articles

Blocking of Cytokine Survival Signals along with Intense Bcr-Abl Kinase Inhibition May Eradicate CML Progenitor Cells.

Devendra K Hiwase, MD, Deborah L White, PhD, Jason A Powell, PhD, Verity A Saunders, Stephanie Zrim, Amity Frede, Mark Guthridge, Richard D'Andrea, PhD, L. Bik To, MD, Junia V. Melo, MD, PhD, Sharad Kumar, PhD, Timothy Hughes, MD
Journal: Blood
Blood (2009) 114 (22): 3250.
https://doi.org/10.1182/blood.V114.22.3250.3250
Published: 2009
Journal Articles

In Contrast to Imatinib, OCT-1 Mediated Influx Has Minimal Impact on Cellular Uptake of Dasatinib in CML Patients at Diagnosis.

Devendra K. Hiwase, MD, Deborah L. White, Verity A. Saunders, Phuong Dang, Amity Venables, Laura Eadie, Steph Zrim, L. Bik To, MD, Junia V. Melo, MD, Timothy P. Hughes, MD
Journal: Blood
Blood (2007) 110 (11): 1937.
https://doi.org/10.1182/blood.V110.11.1937.1937
Published: 2007
Journal Articles

Early Lymphocyte Recovery Predicts Superior Survival after Autologous Peripheral Blood Stem Cell Transplantation (ASCT) in Patients with Multiple Myeloma.

Devendra K. Hiwase, MD, Anthony P. Schwarer, MD, Geraldine M. Bollard, Smita D. Hiwase, MD, Michael Bailey
Journal: Blood
Blood (2005) 106 (11): 5487.
https://doi.org/10.1182/blood.V106.11.5487.5487
Published: 2005